Avrobio's Series A Round

Avrobio raised a round of funding on August 02, 2016.

Avrobio (NASDAQ: AVRO) is a provider of lentiviral-based gene therapies. The company is focused on the development of its programs in Fabry disease and acute myeloid leukemia (AML), while actively bui…

Articles about Avrobio's Series A Round: